Need for a Dedicated Ophthalmic Malignancy Clinico-Biological Biobank: The Nice Ocular MAlignancy (NOMA) Biobank
暂无分享,去创建一个
C. Bertolotto | P. Hofman | B. Mograbi | C. Bonnetaud | S. Baillif | S. Lassalle | K. Washetine | O. Bordone | K. Zahaf | M. Allégra | S. Nahon-Estève | L. Gastaud | A. Martel | S. Lalvée | V. Tanga | V. Lespinet | M. Salah | J. Fayada | Kevin Washetine
[1] L. Jacotot,et al. Utilizing Modular Biobanking Software in Different Types of Biobanking Activities , 2022, Biopreservation and biobanking.
[2] Caressa D Lietman,et al. Treatment of metastatic uveal melanoma in 2022: improved treatment regimens and improved prognosis , 2022, Current opinion in ophthalmology.
[3] Rishvanth K. Prabakar,et al. Potential of Aqueous Humor as a Liquid Biopsy for Uveal Melanoma , 2022, International journal of molecular sciences.
[4] C. Bertolotto,et al. Recent advances in understanding the role of HES6 in cancers , 2022, Theranostics.
[5] Sohita Dhillon. Tebentafusp: First Approval , 2022, Drugs.
[6] J. Thariat,et al. Non-Cancer Effects following Ionizing Irradiation Involving the Eye and Orbit , 2022, Cancers.
[7] B. Esmaeli,et al. Conjunctival melanoma: New insights in tumour genetics and immunology, leading to new therapeutic options , 2021, Progress in Retinal and Eye Research.
[8] H. Grossniklaus,et al. Animal Models of Uveal Melanoma , 2021, Annals of eye science.
[9] X. Xia,et al. The Xiangya Ocular Tumor Bank: A Disease-Specific Biobank for Advancing Translational Research Into Ocular Tumors , 2022, Frontiers in Medicine.
[10] C. Bertolotto,et al. Prognostic Biomarkers in Uveal Melanoma: The Status Quo, Recent Advances and Future Directions , 2021, Cancers.
[11] C. Bertolotto,et al. Small but Challenging Conjunctival Melanoma: New Insights, Paradigms and Future Perspectives , 2021, Cancers.
[12] R. Sullivan,et al. Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma. , 2021, The New England journal of medicine.
[13] I. Biunno,et al. New Challenges for Biobanks: Accreditation to the New ISO 20387:2018 Standard Specific for Biobanks , 2021, Biotech (Basel (Switzerland)).
[14] C. Bertolotto,et al. New Targeted Therapies and Immunotherapies for Locally Advanced Periocular Malignant Tumours: Towards a New ‘Eye-Sparing’ Paradigm? , 2021, Cancers.
[15] D. Fontaine,et al. Phantom vision after eye removal: prevalence, features and related risk factors , 2021, British Journal of Ophthalmology.
[16] C. Bertolotto,et al. Translation of single-cell transcriptomic analysis of uveal melanomas to clinical oncology , 2021, Progress in Retinal and Eye Research.
[17] G. Poissonnet,et al. Efficacy and safety of an artificial dermal graft for the reconstruction of exenterated sockets: a preliminary report , 2021, Graefe's Archive for Clinical and Experimental Ophthalmology.
[18] Gustav Stålhammar,et al. Intratumor Heterogeneity in Uveal Melanoma BAP-1 Expression , 2021, Cancers.
[19] P. Michelow,et al. Ocular surface squamous neoplasia: management and outcomes , 2021, Eye.
[20] C. Bertolotto,et al. Orbital exenteration: an updated review with perspectives. , 2021, Survey of ophthalmology.
[21] K. Bille,et al. Single-cell RNA sequencing reveals intratumoral heterogeneity in primary uveal melanomas and identifies HES6 as a driver of the metastatic disease , 2021, Cell Death & Differentiation.
[22] P. Hofman,et al. PD-L1 Expression in 65 Conjunctival Melanomas and Its Association with Clinical Outcome , 2020, International journal of molecular sciences.
[23] C. Bertolotto,et al. Liquid Biopsy for Solid Ophthalmic Malignancies: An Updated Review and Perspectives , 2020, Cancers.
[24] C. Bertolotto,et al. Endoplasmic reticulum stress mediates resistance to BCL-2 inhibitor in uveal melanoma cells , 2020, Cell Death Discovery.
[25] C. Shields,et al. Uveal melanoma , 2020, Nature Reviews Disease Primers.
[26] A. Klein,et al. Uveal melanoma: Towards a molecular understanding , 2020, Progress in Retinal and Eye Research.
[27] A. Eleuteri,et al. Effects of plaque brachytherapy and proton beam radiotherapy on prognostic testing: a comparison of uveal melanoma genotyped by microsatellite analysis , 2020, British Journal of Ophthalmology.
[28] S. H. van der Burg,et al. Aqueous Humor Biomarkers Identify Three Prognostic Groups in Uveal Melanoma. , 2019, Investigative ophthalmology & visual science.
[29] J. Hicks,et al. Aqueous Humor Is Superior to Blood as a Liquid Biopsy for Retinoblastoma. , 2019, Ophthalmology.
[30] L. Bonaldi,et al. Uveal Melanoma Biopsy: A Review , 2019, Cancers.
[31] S. Roman-Roman,et al. So Close, yet so Far: Discrepancies between Uveal and Other Melanomas. A Position Paper from UM Cure 2020 , 2019, Cancers.
[32] B. Chauffert,et al. The French glioblastoma biobank (FGB): a national clinicobiological database , 2019, Journal of Translational Medicine.
[33] L. Zgaga,et al. National incidence of eyelid cancer in Ireland (2005–2015) , 2019, Eye.
[34] Liya Xu,et al. Aqueous Humor Markers in Retinoblastoma, a Review , 2019, Translational vision science & technology.
[35] W. Yong,et al. An Introduction to Starting a Biobank. , 2018, Methods in molecular biology.
[36] Georges Dagher,et al. Establishing a Dedicated Lung Cancer Biobank at the University Center Hospital of Nice (France). Why and How? , 2018, Cancers.
[37] A. Moulin,et al. [Clinical, radiological, pathological features, treatment and follow-up of periocular and/or orbital amyloidosis: Report of 6 cases and literature review]. , 2018, Journal francais d'ophtalmologie.
[38] C. Shields,et al. Adjuvant Sunitinib in High-Risk Patients with Uveal Melanoma: Comparison with Institutional Controls. , 2017, Ophthalmology.
[39] L. Desjardins,et al. [Management of uveal melanomas, guidelines for oncologists]. , 2018, Bulletin du cancer.
[40] Arun D. Singh,et al. Uveal Melanoma: 5-Year Update on Incidence, Treatment, and Survival (SEER 1973-2013) , 2017, Ocular Oncology and Pathology.
[41] R. Carvajal,et al. Immunotherapy for the Treatment of Uveal Melanoma: Current Status and Emerging Therapies , 2017, Current Oncology Reports.
[42] C. Bertolotto,et al. Focus on cutaneous and uveal melanoma specificities , 2017, Genes & development.
[43] C. Shields,et al. Uveal melanoma: relatively rare but deadly cancer , 2017, Eye.
[44] G. Schwartz,et al. Metastatic disease from uveal melanoma: treatment options and future prospects , 2016, British Journal of Ophthalmology.
[45] J. Thariat,et al. Outcomes After Proton Beam Therapy for Large Choroidal Melanomas in 492 Patients. , 2016, American journal of ophthalmology.
[46] M. Dogrusöz,et al. Radiation Treatment Affects Chromosome Testing in Uveal Melanoma. , 2015, Investigative ophthalmology & visual science.
[47] H. Heimann,et al. Concordant chromosome 3 results in paired choroidal melanoma biopsies and subsequent tumour resection specimens , 2015, British Journal of Ophthalmology.
[48] Yvonne De Souza. Sustainability of Biobanks in the Future. , 2015 .
[49] Gabriele Anton,et al. Public Biobanks: Calculation and Recovery of Costs , 2014, Science Translational Medicine.
[50] P. Hofman,et al. [Immunohistochemistry and personalised medicine in lung oncology: advantages and limitations]. , 2014, Bulletin du cancer.
[51] J. D. de Rooi,et al. The prognostic value of extraocular extension in relation to monosomy 3 and gain of chromosome 8q in uveal melanoma. , 2014, Investigative ophthalmology & visual science.
[52] V. Servois,et al. Detection rate and prognostic value of circulating tumor cells and circulating tumor DNA in metastatic uveal melanoma , 2014, International journal of cancer.
[53] Robert Hewitt,et al. Defining biobank. , 2013, Biopreservation and biobanking.
[54] Kurt Zatloukal,et al. Public–private relationships in biobanking: a still underestimated key component of open innovation , 2013, Virchows Archiv.
[55] David J. Wilson,et al. Collaborative Ocular Oncology Group report number 1: prospective validation of a multi-gene prognostic assay in uveal melanoma. , 2012, Ophthalmology.
[56] Arun D. Singh,et al. Uveal melanoma: trends in incidence, treatment, and survival. , 2011, Ophthalmology.
[57] C. Compton,et al. Biobankonomics: developing a sustainable business model approach for the formation of a human tissue biobank. , 2011, Journal of the National Cancer Institute. Monographs.
[58] Emmanuel Barillot,et al. Genomic profiling and identification of high-risk uveal melanoma by array CGH analysis of primary tumors and liver metastases. , 2009, Investigative ophthalmology & visual science.
[59] K. Bartz-Schmidt,et al. Visualization of Circulating Melanoma Cells in Peripheral Blood of Patients with Primary Uveal Melanoma , 2008, Clinical Cancer Research.
[60] H. Grossniklaus,et al. Animal models of uveal melanoma. , 2000, Melanoma research.